Expression of cyclooxygenase-2 in fine-needle aspirates from breast carcinoma and benign breast diseases

Breast

Volumn 12, Issue 1, 2003, Pages 51-57

  Sucic M ^a   Boban, D ^a   Markovic Glamocak M ^a   Jakic Razumovic J ^a   Vrbanec, D ^a   Ries, S ^a   Gjadrov Kuvezdic K ^a   Cobanov A M ^a   Podolski, P ^a   Martinovic I ^a   Erak, V ^a   Budisic Z ^a   Ivrlac R ^a   Unusic J ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Breast cancer; Cytooxygenase

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; ISOENZYME; PROSTAGLANDIN H2;

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; BREAST DISEASE; BREAST FIBROADENOMA; CARCINOGENESIS; CATALYSIS; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAMMOGRAPHY; MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RATING SCALE; SCORING SYSTEM;

EID: 0037301655     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(02)00281-3     Document Type: Article

References (44)

1. Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998; 90: 455-460.
2. Merlie J P, Fagan D, Mudd J, Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 1988; 263: 3550-3553.
3. Xie W L, Chipman J G, Robertson D L, Erikson R L, Simmons D L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991; 88: 2692-2696.
4. Hla T, Ristimaki A, Appleby S, Barriocanal J G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann NY Acad Sci 1998; 696: 197-204.
5. Sono H, Hla T, Maier J A et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal wall arthritis. J Clin Invest 1992; 89: 97-108.
6. Rolland P H, Martin P M, Jacquemeir J, Rolland A M, Toga M. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 1980; 64: 1061-1070.
7. Bennett A, Charlier E M, McDonald A M, Simpson J S, Stamford I F, Zebro T. Prostaglandins and breast cancer. Lancet 1977; II: 624-626.
8. Levine L. Arachidonic acid transformation and tumor production. Adv Cancer Res 1981; 35: 49-79.
9. Eberhart C E, Coffey R J, Radhika A, Giardiello F M, Ferrenbach S, Dubois R N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188.
10. Ristimaki A, Sivula A, Lundin J et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002; 62: 632-635.
11. Kawabe A, Shimada Y, Uchida S et al. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. J Surg Oncol 2002; 80: 79-88.
12. Lee D W, Sung M W, Park S W et al. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 2002; 22: 2089-2096.
13. Watkins D N, Lenzo J C, Segal A, Garlepp M J, Thompson P J. Expression and localization of cyclo oxygenase isoforms in non-small cell lung cancer. Eur Respir J 1999; 14: 412-418.
14. Tanji N, Kikugawa T, Yokoyama M. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression. Anticancer Res 2000; 20: 2313-2319.
15. Ferrandina G, Lauriola L, Zannoni G F et al. Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients. Ann Oncol 2002; 13: 1205-1211.
16. Marković-Glamočak M, Bohan D, Sučić M, Oberman B, Šćukanec-Špoljar M. Significance of proliferative epithelial changes in breast fine-needle aspiration. Cancer 1992; 70: 781-783.
17. Rogers L A, Lee K R. Breast carcinoma simulating fibroadenoma or fibrocystic change by fine-needle aspiration. Am J Clin Pathol 1992; 98: 155-160.
18. Taxin A, Tartter P I, Zappetti D. Breast cancer diagnosis by fine needle aspiration and excisional biopsy recurrence and survival. Acta Cytol 1997; 41: 302-306.
19. Ghadersohi A, Chitta K, Greco W R et al. Tumor antigens and markers for breast and ovarian cancer. Front Biosci 2002; 7: E48-E57.
20. Perez S A, Sotiropoulou P A, Sotiriadou N N et al. Her-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in vitro-induced CD4(+) T cell clones. Cancer Immunol Immunother 2002; 50: 615-624.
21. Taback B, Chan A D, Kuo C T et al. Detection of occult metastatic breast cancer cells in blood by multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 2001; 61: 8845-8850.
22. Yang Q, Yoshimura G, Suzuma T et al. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. Clin Cancer Res 2001; 12: 3869-3873.
23. Soini Y, Vakkala M, Kahlos K, Paakko P, Kinnula V. MnSOD expression is less frequent in tumor cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cell. J Pathol 2001; 195: 156-162.
24. Brockhoff G, Heiss P, Schlegel J, Hofstaedter F, Knuechel R. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Cytometry 2001; 44: 338-348.
25. Wong S C, Chan J K, Lee K C, Hsiao W L. Differential expression of p16/p21/p27 and cyclin D1/D3 and their relationships to cell proliferation, apoptosis, and tumor progression in invasive ductal carcinoma of the breast. J Pathol 2001; 194: 35-42.
26. Pandis N, Jin Y, Goruna L et al. Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups. Genes Chromosomes Cancer 1995; 12: 173-185.
27. Nishizaki T, DeVries S, Chew K et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromsomes Cancer 1997; 19: 267-272.
28. Ohyashiki K, Ohyashiki J H, Nishimaki J et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997; 57: 2100-2103.
29. Mirza A N, Mirza N Q, Vlastos G, Singletary S E. Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 2002; 1: 10-26.
30. Marković-Glamočak M, Sučić M, Bohan D. Fine-needle aspiration and nipple discharge cytology in the diagnosis of breast lesions in adolescent and young women: cytologic findings as compared with those obtained in older women. Adolesc Pediatr Gynecol 1994; 7: 205-209.
31. Cordell J L, Fallini B, Erber W N et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). I Histochem Cytochem 1984; 32: 219-229.
32. Sučić M, Boban D, Marković-Glamočak M et al. Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypes. J Hematother Stem Cell Res 1999; 8: 635-643.
33. Flowers J L, Burton G U, Cox E B et al. Use of monoclonal anti-estrogen receptor to evaluate estrogen receptor content in fine-needle aspiration breast biopsies. Ann Surg 1986; 203: 250-254.
34. Hintze J L. Number Cruncher Statistical System. Kaysville, Utah, 1987.
35. Costa C, Soares R, Reis-Filho J S, Leitao D, Amendoeira I, Schmitt F C. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 2002; 55: 429-434.
36. Remmele W, Schicketanz K H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 1993; 189: 862-866.
37. Kohlberger P D, Breitenecker F, Kaider A et al. Modified true-color computer image analysis versus subjective scoring of estrogen receptor expression in breast cancer: a comparison. Anticancer Res 1999; 19 (3B): 2189-2193.
38. Half E, Tang X M, Gwyn K, Sahin A, Wathen K, Sinicrope F A. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Cancer Res 2002; 62: 1676-1681.
39. Parfenova H, Parfenov V N, Shlopov BV et al. Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells. Am J Physiol Cell Physiol 2001; 281: C166-C178.
40. Masferrer J. Approach to angiogenesis inhibition based on cyclooxygenase. Cancer J 2001; 7 (Suppl 3): S144-S150.
41. Bing R J, Miyataka M, Rich K A et al. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. Clin Cancer Res 2001; 11: 3385-3392.
42. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-809.
43. Tsujii M, DuBois R N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
44. Müller A, Homey B, Müller J et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56.